Hysteroscopy
Conditions
Interventions
Control group A:Receiving alfentanil combined with propofol anesthesia
Experimental group B:Received anesthesia with alfentanil combined with ciprofloxacin
Experimental group C:Received anesthesia with alfentanil combined with remazolam benzenesulfonate
Sponsors
Gansu Provincial Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Voluntarily sign the informed consent form for this study; 2. Stable vital signs, aged between 18 and 60 years; 3. Hysteroscopy or treatment for various reasons; 4. ASA Grades I–II; 5. No allergy to anesthetic drugs, and no contraindications to anesthesia.
Exclusion criteria
Exclusion criteria: 1. Patients with difficult airway, modified Mallampati score of grade III or IV; 2. Patients with respiratory or cardiac dysfunction; 3. Abnormal blood routine or blood biochemical examination before hysteroscopy, suffering from severe neuropsychiatric diseases; 4. Patients who have used benzodiazepines or opioids intermittently in the past 1 month or the past 3 months; 5. Patients with allergies or contraindications to benzodiazepines, opioids, propofol, flumazenil or naloxone; 6. Unaccompanied or guardian; 7. Patients with abnormal hearing and vision, unable to communicate normally; 8. Patients who are unable to provide or refuse to sign the informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of intraoperative hypoxemia; | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient and anesthesiologist satisfaction;Incidence of other adverse reactions;Intraoperative mean arterial pressure, heart rate and oxygen saturation;Intraoperative operation time, awakening time and time out of the room; | — |
Countries
China
Contacts
Public ContactWang Dong
Gansu Provincial People's Hospital
Outcome results
None listed